Latest Digital Platforms News

Vista Group International is set to roll out its Digital Enablement platform across 88 Cineworld cinemas in the UK during 2026, building on last year’s deployment at 25 Picturehouse sites.

Doctor Care Anywhere has snapped up the GLP-1 and medicated weight-loss business of Outcome Diagnostics and MedicSpot for £850,000, adding £5.3 million in trailing revenue and expanding its direct-to-consumer footprint in the UK.

ARN Media reported a 10% revenue decline in FY25 but accelerated digital growth and cost savings, while defending ongoing legal disputes with former talent.

Smartgroup delivered a robust start to 2026 with double-digit growth in novated leasing orders and a new app rollout, while targeting mid-40s EBITDA margins for 2027 amid supportive EV policies.

Woolworths Group posted a 4.5% increase in third quarter sales, led by strong Australian Food and WooliesX eCommerce growth, while signaling cautious EBIT guidance due to inflation and Middle East conflict impacts.

Carma Limited surged past prior year sales with 1,344 units sold, boosted by rapid network expansion and improved reconditioning efficiency, while maintaining a solid cash position.

EVE Health Group has begun commercial sales of Libbo, an oral dissolving film for erectile dysfunction, supported by a new digital men’s health platform. The company also expanded its pharmaceutical pipeline and secured $1.3 million in fresh capital to fund ongoing development and commercialization.

Singular Health boosted its US presence by deploying 500 additional 3DICOM MD® licenses to Provider Network Solutions, securing FDA 510(k) clearance for its cloud platform, and launching education pilots with Miami-Dade schools and Florida International University.

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

333D Ltd (ASX:T3D) reversed its prior quarter’s cash outflow to report a $71,505 positive operating cash flow for March 2026, driven by growing healthcare digital asset contracts and a strategic Bitcoin holding. The company also deployed $95,800 post-quarter to scale its healthcare-focused platform.

Airtasker Limited posted robust 3Q26 results highlighted by strong Australian marketplace momentum and explosive growth in the UK and US. The company reaffirmed its FY26 guidance, underpinned by strategic media partnerships and a solid cash position.

BCAL Diagnostics has expanded its Avantect cancer blood tests nationally through major pathology networks, generating $88,000 in Q3 revenue from 91 tests. The company also submitted an initial Medicare reimbursement application for pancreatic cancer detection and is preparing to launch an enhanced BREASTESTplus 2.0 test in early 2027.